Company Name

Drug

Event

Outcome

Details

Ardelyx, Inc
(ARDX)

Tenapanor (NDA)

07/29/2021
FDA decision on Tenapanor for control of serum phosphorus in adult patients with chronic kidney disease on dialysis

FDA issued a Complete Response Letter for Tenapanor on Jul.29, 2021-

Rival Drugs

Market Potential

Sol-Gel Technologies Ltd.
(SLGL)

Twyneo (NDA)

08/01/2021
FDA decision on Twyneo for the treatment of acne vulgaris

FDA approved Twyneo for the treatment of acne vulgaris on Jul.27, 2021-

Rival Drugs

Market Potential

Pfizer Inc.
(PFE)

TicoVac (BLA)

Aug 2021
FDA decision on TicoVac vaccine for tick-borne encephalitis

Approved in Other Countries